Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway.

Cripto-1 (CR-1) is a recently discovered protein of the epidermal growth factor family that does not directly activate any of the known erbB type 1 tyrosine kinase receptors. Also, CR-1 stimulates the growth of HC-11 mouse mammary epithelial cells. We found that prior treatment of HC-11 cells with exogenous CR-1 induced a competency response to the lactogenic hormones dexamethasone, insulin, and prolactin (DIP) with respect to the induction of the milk protein beta-casein. In contrast, simultaneous treatment of mouse HC-11 cells with CR-1 in the presence of DIP inhibited beta-casein expression. The inhibitory effects of CR-1 on beta-casein expression in response to DIP were not unique to this mouse mammary epithelial cell line, because beta-casein and whey acidic protein expression in primary mouse mammary explant cultures established from midpregnant mice were also differentially inhibited by several epidermal growth factor-related peptides including CR-1. The mitogenic and differentiation effects of CR-1 are mediated by the binding of CR-1 to a cell surface receptor that is known to activate the ras/raf/mitogen-activated protein kinase (MAPK)/MAPK kinase pathway. The inhibitory response of CR-1 in HC-11 cells on beta-casein expression after treatment with DIP can be attenuated by B581, a peptidomimetic farnesyltransferase inhibitor that blocks p21ras farnesylation and activation, and by the phosphatidylinositol 3'-kinase (PI3k) inhibitor LY 294002 but not by PD 98059, a MAPK kinase inhibitor that blocks MAPK activation. These data suggest that the ability of CR-1 to block lactogenic hormone-induced expression of beta-casein is mediated through a p21ras-dependent, PI3k-mediated pathway. This is further substantiated by the observation that CR-1 is able to stimulate the tyrosine phosphorylation of the p85 PI3k regulatory subunit and to increase the activity of PI3k in HC-11 cells.

[1]  D. Salomon,et al.  Expression of epidermal growth factor‐related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis , 1997, Journal of cellular physiology.

[2]  B. Groner,et al.  Lactogenic Hormone Activation of Stat5 and Transcription of the β-Casein Gene in Mammary Epithelial Cells Is Independent of p42 ERK2 Mitogen-activated Protein Kinase Activity* , 1996, The Journal of Biological Chemistry.

[3]  N. Rahimi,et al.  Phosphatidylinositol 3-Kinase Activity Is Required for Hepatocyte Growth Factor-induced Mitogenic Signals in Epithelial Cells* , 1996, The Journal of Biological Chemistry.

[4]  L. Cantley,et al.  Phosphoinositide 3-kinase and the regulation of cell growth. , 1996, Biochimica et biophysica acta.

[5]  L. Hennighausen,et al.  Understanding mammary gland development through the imbalanced expression of growth regulators , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[6]  K. Al-Sakkaf,et al.  Activation of phosphatidylinositol 3-kinase by prolactin in Nb2 cells. , 1996, Biochemical and biophysical research communications.

[7]  D. Salomon,et al.  Detection of amphiregulin and Cripto‐1 in mammary tumors from transgenic mice , 1996, Molecular carcinogenesis.

[8]  W. Birchmeier,et al.  Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland , 1995, The Journal of cell biology.

[9]  L. Bobrow,et al.  Amphiregulin and cripto overexpression in breast-cancer - relationship with prognosis and clinical and molecular-variables. , 1995, International journal of oncology.

[10]  L. Hennighausen,et al.  Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. , 1995, Development.

[11]  D. Salomon,et al.  Detection and location of amphiregulin and Cripto‐1 expression in the developing postnatal mouse mammary gland , 1995, Molecular reproduction and development.

[12]  A. Saltiel,et al.  Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor(*) , 1995, The Journal of Biological Chemistry.

[13]  B. Erdmann,et al.  EGF and TGFα modulate structural and functional differentiation of the mammary gland from pregnant mice in vitro: Possible role of the arachidonic acid pathway , 1995, Journal of cellular biochemistry.

[14]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[15]  D. Taverna,et al.  NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. , 1995, Oncogene.

[16]  D. Salomon,et al.  Members of the fatty acid binding protein family are differentiation factors for the mammary gland , 1994, The Journal of cell biology.

[17]  L. Cantley,et al.  A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling , 1994, Cell.

[18]  N. Normanno,et al.  Identification and biological characterization of an epidermal growth factor-related protein: cripto-1. , 1994, The Journal of biological chemistry.

[19]  Y. Yarden,et al.  Neu and its ligands: From an oncogene to neural factors , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[20]  M. Lewis,et al.  Peptidomimetic inhibitors of Ras farnesylation and function in whole cells. , 1993, The Journal of biological chemistry.

[21]  M. Bissell,et al.  Multi‐faceted regulation of cell differentiation by extracellular matrix , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  A. Ciccodicola,et al.  Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. , 1991, American journal of human genetics.

[23]  D. Taverna,et al.  Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  D. Salomon,et al.  Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. , 1991, Cancer research.

[25]  B. Groner,et al.  Prolactin regulation of beta‐casein gene expression and of a cytosolic 120‐kd protein in a cloned mouse mammary epithelial cell line. , 1988, The EMBO journal.

[26]  B. Vonderhaar.  Local effects of EGF, α‐TGF, and EGF‐like growth factors on lobuloalveolar development of the mouse mammary gland in vivo , 1987 .

[27]  H. Nakhasi,et al.  Bifunctional activity of epidermal growth factor on α- and κ-casein gene expression in rodent mammary glands in vitro , 1986 .

[28]  D. Taverna,et al.  Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. , 1995, Molecular endocrinology.

[29]  C. Daniel,et al.  Local effects of growth factors , 1991 .

[30]  Daniel Cw,et al.  Regulatory mechanisms in breast cancer. Local effects of growth factors. , 1991 .

[31]  B. Vonderhaar.  Regulation of development of the normal mammary gland by hormones and growth factors. , 1988, Cancer treatment and research.